RapidShock analysis added to Zoll AEDs

ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, has announced that the company’s ZOLL AED 3 and the ZOLL AED BLS automated external defibrillators now feature RapidShock Analysis technology, which decreases heart analysis time and pauses in chest compressions. RapidShock Analysis can analyse a heart rhythm in three seconds - existing devices can take up to 12 seconds. Minimising CPR pause time for more continuous lifesaving CPR care can improve patient outcomes from sudden cardiac arrest. RapidShock Analysis is a free upgrade to existing ZOLL AED 3 owners in countries where it has regulatory approval.

“We’re pleased to be able to add this breakthrough technology to the ZOLL AED 3. It is critical to deliver consistent, high-quality chest compressions, and this technology dramatically reduces pauses, allowing for high-quality CPR,” said A. Ernest Whiton, president of ZOLL Resuscitation.